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Table. Patency rates
Patients
1-year primary
patency,
1-year primary
assisted patency,
1-year secondary
patency,
% (95% CI) % (95% CI) % (95% CI)
All patients 90 (82-96) 94 (87-98) 95 (88-99)
Bypass
AFB 88 (60-98) 94 (68-99) 100 (76-100)
Extra-anatomic 92 (81-97) 92 (81-97) 93 (83-98)
Endarterectomy 100 (40-100) 100 (40-100) 100 (40-100)
Other bypass 100 (52-100) 100 (52-100) 100 (52-100)
AFB, Aortobifemoral bypass; CI, conﬁdence interval.
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824 Abstracts September 2014FEVAR patients (area under the curve ¼ 0.87 for both groups). There were
39% (n ¼ 177), 41% (n ¼ 187), and 20% (n ¼ 95) low-risk, intermediate-
risk, and high-risk patients, respectively. The comparative outcomes of open
vs FEVAR by risk strata are presented in the Table.
Conclusions: Favorable outcomes for FEVAR observed in high-risk
patients likely reﬂect differences in clinical presentation; however, this anal-
ysis of early experience with FEVAR suggests comparable outcomes for
open and FEVAR repair in low-risk and intermediate-risk patients.
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Objectives: Aortoiliac occlusive disease is a common manifestation of
peripheral vascular disease. As reﬂected by the changes made in the Inter-
Society Consensus for the Management of Peripheral Arterial Disease II
guidelines, endovascular therapy is now the preferred modality for treatment
in most patients. Some patients are not candidates for an endovascular
approach due to their anatomy or prior interventions. Other patients may
be better managed with open repair to preserve future endovascular options
and allow access for contralateral infrainguinal interventions. This study
investigated the indications for and outcomes of open operations for aortoil-
iac occlusive disease in a contemporary patient series.
Methods: Two afﬁliated hospitals’ prospective databases were sur-
veyed retrospectively. All patients who underwent an open operation for
aortoiliac occlusive disease during a 5-year period from 2008 to 2012
were included in the analysis. Statistical analysis was performed using the
Student t-test and Kaplan-Meier techniques.
Results: We identiﬁed 87 patients (69% male) who had open opera-
tions for aortoiliac occlusive disease. Mean follow up was 17.4 months.
Average patient age was 64 years, and mean American Society of Anesthe-
siologists score was 3.1. Procedures included 16 aortobifemoral bypasses, 4
aortic endarterectomies, 61 extra-anatomic bypasses, 6 other bypasses, and
9 involved a combined endovascular procedure. The primary indications for
surgery were chronic occlusive disease in 79 patients (22 rest pain, 18 tissue
loss, 39 claudication) and acute limb ischemia with threatened limb in eight
patients. The main indication for open operation in (84%) of patients was
extent of disease. Twenty-one percent underwent unsuccessful attempts atTable. Cost data from two academic medical centers
EVAR patient
Center A factors P Center B factors P
Iliac aneurysm .01 Transferred .01
CABG/PTCA <5 years .04 AAA diameter .04
Reduced EF .04
Elevated creat .02
EVAR procedural
Cover Int Iliac .006 Graft vendor .007
Other art proc .002 OR coiling .03
EBL <.0001 Unplanned ext .01
IVF <.0001 Art inj reg ext .01
Proc time <.0001 EBL .0007
IVF .002
Proc time .0001
Dysrhythmia .01 Return OR .01
Resp comp .02 ICU stay .049
Renal failure .04
AAA, Abdominal aortic aneurysm; CABG, coronary artery bypass grafting; CO
ejection fraction; EVAR, endovascular aneurysm repair; ICU, intensive care un
PTCA, percutaneous transluminal angioplasty.
>Eastern Vascular Societyendovascular treatment before open repair. Previous interventions were
common: 22% had prior failed bypass and 38% had prior failed endovascular
intervention. Patency rates at 1 year were as noted in the Table. The compli-
cation rate was 43%, and most were wound related. Major amputation rate
was 8%, and perioperative mortality was 3.4% (n ¼ 3).
Conclusions: In the setting of the current “endovascular ﬁrst” para-
digm, open surgery for aortoiliac occlusive disease remains an important
revascularization option, especially for patients with diffuse disease. Short-
term patency rates remain excellent, even in these patients who were either
not candidates for or failed endovascular treatment. Future vascular trainees
will continue to need these options in their armamentarium.
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Objectives: Cost data from two academic medical centers were exam-
ined to determine patient characteristics and/or clinical events that are pre-
dictive of high cost hospitalizations after elective endovascular (EVAR) and
open (OAAA) abdominal aortic aneurysm repair. Elements of patient selec-
tion, operative performance, and postoperative complications were exam-
ined for their inﬂuence on cost.OAAA patient
Center A P Center B P
Red EF .04 CHF .03
COPD e meds .02 b-Blockers (protective) .04
Prior bypass .01 COPD-all .01
Transfer .048
Age .002
OAAA procedural
Anesthesia .05 Exposure <.0001
Exposure .002 EBL .03
Clamp position .0001 IVF .0004
EBL .004 Proc time <.0001
IVF .0003
Proc time .0004
Dysrhythmia <.0001 Dysrhythmia <.0001
Resp comp <.0001 Resp comp <.0001
Renal failure .008 Renal failure .0005
PD, chronic obstructive pulmonary disease; EBL, estimated blood loss; EF,
it; OAAA, open abdominal aortic aneurysm repair; OR, operating room;
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